With many regions of the world seeing a rise in severe acute respiratory syndromecoronavirus 2 (SARS-CoV-2) cases, borders, schools, and workplaces are partially...
There is evidence that COVID-19 threatens maternal and perinatal health. Pregnantwomen, especially in the second half of pregnancy, are at increased risk of complications—eg,...
Covaxin is India's first indigenous vaccine against severe acute respiratory syndromecoronavirus 2 (SARS-CoV-2), developed through a collaboration between Bharat...
Published: January 24, 2021Executive Summary The Lancet Series on Womens and Childrens Health in Conflict Settings aims to improve understanding of and address the special requirements...
Radiotherapy activity fell significantly, but use of hypofractionated regimens rapidlyincreased in the English NHS during the first peak of the COVID-19 pandemic....
Land borders have been closed and restrictions continue as a new variant stresses the health system. Munyaradzi Makoni reports.
While the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)on the nervous system remain unclear, there is no doubt that the COVID-19 pandemic...
COVID-19 cases are very high across Europe. Current measures are not reducing virusspread sufficiently, and new SARS-CoV-2 variants are emerging. The B.1.1.7 and...
The race to develop safe, effective vaccines against severe acute respiratory syndromecoronavirus 2 (SARS-CoV-2) has produced impressive results. As of Jan 18,...
We read with interest the Article by Chris Gale and colleagues reporting data fromactive surveillance of neonatal severe acute respiratory syndrome coronavirus...